Concomitant Driver Mutations in Advanced Stage Non-Small-Cell Lung Cancer of Adenocarcinoma Subtype with Activating EGFR-Mutation

被引:0
|
作者
Sorensen, Jens Benn [1 ]
Grauslund, Morten [2 ]
Melchior, Linea [2 ]
Jakobsen, Jan [1 ]
Santoni-Rugiu, Eric [2 ]
机构
[1] Natl Univ Hosp, Finsen Ctr, Dept Oncol, Copenhagen, Denmark
[2] Natl Univ Hosp, Dept Pathol, Copenhagen, Denmark
关键词
EGFR mutation; next generation sequencing; MET amplification; MET expression;
D O I
10.1016/j.jtho.2016.11.635
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.02-051
引用
收藏
页码:S518 / S519
页数:3
相关论文
共 50 条
  • [31] Immunohistochemistry with Mutation Specific Antibodies Detecting the Status of EGFR Mutations in Non-Small-Cell Lung Cancer
    Li, D.
    Chen, S.
    Hu, C.
    Lei, Y.
    Yu, J.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 407A - 407A
  • [32] Immunohistochemistry with Mutation Specific Antibodies Detecting the Status of EGFR Mutations in Non-Small-Cell Lung Cancer
    Li, D.
    Chen, S.
    Hu, C.
    Lei, Y.
    Yu, J.
    [J]. MODERN PATHOLOGY, 2010, 23 : 407A - 407A
  • [33] Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
    Rosell, Rafael
    Aguilar-Hernandez, Andres
    Gonzalez-Cao, Maria
    [J]. CANCERS, 2023, 15 (09)
  • [34] NON SMALL CELL LUNG CANCER(NSCLC) WITH ACTIVATING EGFR MUTATION IN CHILE
    Aren, Osvaldo
    Voge, Conrado
    Orellana, Eric
    Kleinmann, Sergio
    Fica, Mauricio
    Cerda, Humberto
    Suarez, Claudio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1515 - S1515
  • [35] The treatment of advanced lung adenocarcinoma with activating EGFR mutations
    Rocco, Danilo
    Della Gravara, Luigi
    Battiloro, Ciro
    Maione, Paolo
    Gridelli, Cesare
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (18) : 2475 - 2482
  • [36] EGFR mutation positive stage IV non-small-cell lung cancer: treatment beyond progression
    Van Assche, Katrijn
    Ferdinande, Liesbeth
    Lievens, Yolande
    Vandecasteele, Katrien
    Surmont, Veerle
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [37] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    Gazdar, A. F.
    [J]. ONCOGENE, 2009, 28 : S24 - S31
  • [38] Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
    A F Gazdar
    [J]. Oncogene, 2009, 28 : S24 - S31
  • [39] A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
    Shi, Yuankai
    Au, Joseph Siu-Kie
    Thongprasert, Sumitra
    Srinivasan, Sankar
    Tsai, Chun-Ming
    Khoa, Mai Trong
    Heeroma, Karin
    Itoh, Yohji
    Cornelio, Gerardo
    Yang, Pan-Chyr
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (02) : 154 - 162
  • [40] EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer
    Fang, Shu
    Wang, Zhehai
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 1595 - 1611